BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 5:28:00 PM | Browse: 1181 | Download: 1388
 |
Received |
|
2014-02-10 16:36 |
 |
Peer-Review Started |
|
2014-02-10 21:16 |
 |
To Make the First Decision |
|
2014-03-12 16:42 |
 |
Return for Revision |
|
2014-03-20 20:41 |
 |
Revised |
|
2014-05-07 06:46 |
 |
Second Decision |
|
2014-05-29 08:55 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-05-29 09:44 |
 |
Articles in Press |
|
2014-05-29 11:55 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-07-25 11:49 |
 |
Publish the Manuscript Online |
|
2014-08-01 16:16 |
Category |
Oncology |
Manuscript Type |
Topic Highlights |
Article Title |
Review of the current targeted therapies for non-small-cell lung cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Kim-Son H Nguyen, Joel W Neal and Heather Wakelee |
Funding Agency and Grant Number |
|
Corresponding Author |
Heather Wakelee, MD, Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States. hwakelee@stanford.edu |
Key Words |
Lung cancer; Non-small cell lung cancer; Targeted therapies; Epidermal growth factor receptor; Epidermal growth factor receptor; Anaplastic lymphoma kinase; Acquired resistance |
Core Tip |
The development of oncogene-directed targeted therapies has significantly changed the treatment of non-small-cell lung cancer. We review the data demonstrating efficacy of small-molecule tyrosine kinase inhibitors against epidermal growth factor receptor, anaplastic lymphoma kinase, ROS1, and other oncogenes. We also discuss the challenge of acquired resistance to these therapies and review promising agents which may overcome resistance. |
Publish Date |
2014-08-01 16:16 |
Citation |
Nguyen KSH, Neal JW, Wakelee H. Review of the current targeted therapies for non-small-cell lung cancer. World J Clin Oncol 2014; 5(4): 576-587 |
URL |
http://www.wjgnet.com/2218-4333/full/v5/i4/576.htm |
DOI |
http://dx.doi.org/10.5306/wjco.v5.i4.576 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345